The North Carolina Department of Environmental Quality is hosting an in-person community information session on Tuesday, July 26, at 6 p.m. in the Crown Theatre.
Officials will be in attendance to share information and answer questions about the Environmental Protection Agency’s health advisory for the chemical GenX and the impacts it is having on private drinking water in Cumberland, Bladen, Robeson and Sampson Counties.
Along with additional information being provided, the DEQ’s air, water and waste management will give updates as well. Officials from the North Carolina Department of Health and Human Services will also explain health effects and ways to limit exposure.
“On June 15, the EPA set a final lifetime health advisory level for GenX of 10 parts per trillion, which replaces the state’s provisional drinking water health goal of 140 ppt developed by NCDHHS,” stated a press release.
DEQ estimated that more than 1,700 additional private well users will be eligible for whole-building filtration for a public water supply. Nearly 1,300 of those reside in Cumberland County.
Information for residents in Bladen, Cumberland, Robeson and Sampson Counties can be found here.
Cumberland County’s Public Information Office will record the meeting and post the video at a later date on their website.
Anyone with questions is encouraged to attend.
What an impactful month March is! We get to honor the women in our lives throughout the month of March, and more specifically on March 8 for International Women’s Day. We also get to celebrate the beginning of new life in spring which coincidentally
It is a season of growth for Linchpin Solutions, Inc. as they welcome in their new Vice President of Learning Solutions, Kathryn Cox. Cox has been developing training and education programs for customers for over 30 years, building up her impressive
Based in Cary, NC, Optimal Bio currently has four established locationsacross North Carolina, including one in Southern Pines, NC. PHOTOS TAKEN BY SARAH MORREL PHOTOGRAPHYTylar Brannon, the chief executive officer of Bioidentical Hormone Replacement